Enterprise Products Partners offers an ultra-high distribution yield plus solid growth prospects. Intel could roar back with a massive AI tailwind.
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
Take the quiz below to get matched with a financial advisor today. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Since my last article, the company's share price has fallen about 10% despite its quarterly revenue growth and achieving significant success in developing experimental drugs. In addition to growing sa
Today, I will present you with two attractive high dividend yield companies that can help to enhance your dividend income. I have added both companies to The Dividend Income Accelerator Portfolio. Thi
Pfizer's stock has been a disappointment in recent times due to a number of factors. This includes a decline in Covid cases as well as looming patent protection expirations.
The markets declined for the second consecutive week, causing a retracement in the Dividend Harvesting Portfolio. Dividend income generated in week 163 was light, but the portfolio's forward projected
Hidden treasures sometimes go overlooked in the busy world of financial markets. Here, attention is frequently drawn to the names with the most sparkle.

Buy 11 MediaMade April ProActive Dividend Dogs

04:27pm, Wednesday, 17'th Apr 2024
On April 1, 2024, Barron's, Bloomberg, and Kiplinger analysts listed four sets of stocks here-named ProActive for 2024. Those four articles revealed 28 equities, with 24 paying-dividends. The four Pro

3 No-Brainer Stocks to Buy With $100 Right Now

05:21am, Wednesday, 17'th Apr 2024
Since Wall Street's major stock indexes tend to rise over the long run, anytime can be the ideal time to put money to work. Most online brokers have done away with minimum deposit requirements and com
A couple of big-picture trends in biotech could add up to a nice investment opportunity. First, corporate buyouts are back in style.

Pfizer's Doldrums, Just A Bad Case Of COVID-19?

09:15am, Tuesday, 16'th Apr 2024
PFE's dividend has reached the sky-high (for a biotech) ~6% mark. Are the dividend and recent share price decline enough to make PFE an attractive play? PFE is following a similar trajectory to GILD i
Pfizer (PFE) closed the most recent trading day at $25.91, moving +0.19% from the previous trading session.

Is Pfizer Stock a Buy?

08:45am, Monday, 15'th Apr 2024
Pfizer has been struggling since its coronavirus vaccine sales started to fall. It's making a big move into cancer drugs, which should help it diversify.
Pfizer lost heaps of COVID-19 revenue, but a slate of new drugs could lead to steady gains for patient investors. Ares Capital is a well-managed business development company that offers investors a 9.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE